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ABSTRACT: HERC2 is a large E3 ubiquitin ligase with
multiple structural domains that has been implicated in an
array of cellular processes. Mutations in HERC2 are linked to
developmental delays and impairment caused by nervous
system dysfunction, such as Angelman Syndrome and autism-
spectrum disorders. However, HERC2 cellular activity and
regulation remain poorly understood. We used a broad
proteomic approach to survey the landscape of cellular
proteins that interact with HERC2. We identiﬁed nearly 300
potential interactors, a subset of which we validated binding to
HERC2. The potential HERC2 interactors included the
eukaryotic translation initiation factor 3 complex, the intra-
cellular transport COPI coatomer complex, the glycogen
regulator phosphorylase kinase, beta-catenin, PI3 kinase, and proteins involved in fatty acid transport and iron homeostasis.
Through a complex bioinformatic analysis of potential interactors, we linked HERC2 to cellular processes including intracellular
protein traﬃcking and transport, metabolism of cellular energy, and protein translation. Given its size, multidomain structure, and
association with various cellular activities, HERC2 may function as a scaﬀold to integrate protein complexes and bridge critical
cellular pathways. This work provides a signiﬁcant resource with which to interrogate HERC2 function more deeply and evaluate
its contributions to mechanisms governing cellular homeostasis and disease.
KEYWORDS: HERC2, UBE3A (E6AP), eIF3, translation, translational initiation, intracellular transport, vesicle-mediated transport,
cellular energy metabolism
■ INTRODUCTION
HERC2 is one of the six members of the HERC family of
proteins, each of which possesses at least one regulator of
chromosome condensation 1 (RCC1)-like domain (RLD) and
a homologous to E6AP carboxy terminus (HECT) domain
characteristic of a group of ubiquitin ligases.1−3 The HERC2
protein is comprised of 4834 amino acids with a molecular
weight exceeding 500 kDa and contains multiple structural
domains.2,4 Mutations in the HERC2 gene have been linked to
neurodevelopmental delay and dysfunction seen in both
Angelman Syndrome and autism-spectrum disorders;5,6 how-
ever the role of HERC2 in these disorders is unknown and
underlies the need for a greater understanding of HERC2
function.
To date, the most widely studied function of HERC2
involves the cellular response to DNA damage. HERC2 has
been reported to interact with RNF8 at double-stranded DNA
breaks, and HERC2 expression is required for RNF8-mediated
histone ubiquitylation, as well as the recruitment and retention
of downstream repair factors.7 HERC2 has also been reported
to interact with and regulate the stability of the RING ubiquitin
ligase BRCA1 and the nucleotide excision repair factor
Xeroderma pigmentosum A (XPA),8−11 potentially through
ubiquitin-mediated proteasomal degradation.9,11 BRCA1 also
aﬀects HERC2 binding with claspin, an upstream regulator of
the checkpoint kinase Chk1 and facilitator of ATR-dependent
Chk1 phosphorylation.12 Despite the interactions between
HERC2 and proteins important for maintaining genomic
integrity and repair, the function of HERC2 in these processes
remains largely unknown.
More recently, HERC2 was shown to interact with p53
through the p53 tetramerization domain, thus aﬀecting p53
oligomerization and downstream transcriptional activity.13
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HERC2 also interacts with the deubiquitinating enzyme USP33
and the SCF protein FBXL5, regulating their stability through
ubiquitin-mediated proteasomal degradation.14,15 HERC2 has
also been shown to regulate centrosome morphology and
ubiquitin ligase activity through interactions with NEURL4 and
UBE3A (also known as E6AP), respectively. NEURL4 and
HERC2 were identiﬁed as interactors of the centrosomal
protein CP110, and their binding is required for maintenance
of centrosome integrity.16,17 E6AP was the ﬁrst mammalian E3
ubiquitin ligase to be identiﬁed, and its association with the
human papillomavirus (HPV) oncoprotein E6 was shown to
redirect the E6AP ligase activity to mediate the ubiquitylation
of p53, resulting in p53 proteasomal degradation.18,19 HERC2
complexes with E6AP bound to E6 in HPV16-positive cells20
and regulates E6AP ligase activity in HEK 293T cells.21 Our
laboratory showed that HERC2 interacts with NEURL4 and
E6AP, along with the serine/threonine kinase MAPK6, in a
large molecular weight complex of at least 2 MDa.22 No
function has yet been described for this complex, but its size
and multiple domains suggest that it may serve as a platform
coordinating the activities of several interacting proteins.
To more widely probe the landscape of cellular HERC2
interactions, we undertook a mass spectrometry (MS)-based
proteomic approach to identify and validate additional HERC2
interacting proteins. Our analysis identiﬁed close to three
hundred putative HERC2 interactors that are involved in
distinct biological processes including vesicular transport,
organelle organization, GTP-associated signal transduction,
protein translation, energy and iron metabolism, and DNA
repair. We used bioinformatics to identify cellular pathways
through which HERC2 may function, and we have validated
more than a dozen new HERC2−protein interactions. These
interacting partners implicate HERC2 in cellular protein
transport, energy metabolism, and protein synthesis. Because
of its size, various structural domains, and ability to bind
multiple partners, HERC2 is likely involved in a variety of
cellular functions and might serve as a platform to integrate
diﬀerent intracellular functions. Our proteomic analysis
provides a substantial resource for subsequent in-depth studies
of HERC2 cellular function.
■ EXPERIMENTAL PROCEDURES
Plasmids and Cloning
The HERC2 expression plasmids were obtained from Neils
Mailand7 in the pFlag-CMV2 vector (Sigma). To generate
vectors containing the amino terminal hemagglutinin tag (N-
HA) for expression of the individual HERC2 fragments, the
pFlag-CMV2 vectors were ampliﬁed by PCR with primers for
recombination in the pDONR223 vector (Invitrogen). The
forward and reverse primers for each fragment were designed
containing the recombination sequence as a leader (forward: 5′-
GGGGACAACTTTGTACAAAAAAGTTGG-3′, reverse: 5′-
GGGGACAACTTTGTACAAGAAAGTTGGGTC-3′) up-
stream of the coding sequence for each fragment. The
remaining primer sequences for each HERC2 fragment
(following the recombination leader sequence) are fragment
1 (F1, amino acids 1−1000) forward 5′-CATGCCCTC-
TGAATCTTTCTGTTTGG-3′ and reverse 5′-AAGACTCAC-
AGATCCCCGTATTAATAAGG-3′, fragment 2 (F2, amino
acids 950−1750) forward 5′-CGCAGCCATTACTGCA-
GAGATCC-3′ and reverse 5′-AGGCATCCATCAAAA-
CATTTCG-3′, fragment 3 (F3, amino acids 1700−2700)
forward 5′-CATTCCTGAGGGAATCG-3′ and reverse 5′-
AGGGTACCAACTCCATTTC-3′, fragment 4 (F4, amino
acids 2600−3600) forward 5′-CGATGGATTGCATGA-
TCTCAATGTGC-3′ and reverse 5′-ATGTGGCCAC-
ATCCTCCAACTCGG-3′, fragment 5 (F5, amino acids
3550−4500) forward 5′-CGTAGACCTGCTCAAGC-3′ and
reverse 5′-ACAGGGGCGTGAGTCCG-3′, fragment 6 (F6,
amino acids 4421−4834) forward 5′-CAACCGCATCCAGG-
TCAAACG-3′ and reverse 5′-AGTGTCCTGTTAAATAA-
TCTTG-3′. Following PCR ampliﬁcation and BP recombina-
tion into pDONR223, each HERC2 fragment was then
recombined (LR recombination) into the vector pHAGE-P
CMVt N-HA GAW, where GAW indicates GATEWAY
cassette. A 6.5 kb fragment encoding the carboxy-terminal
half of the HERC2 gene (F456, amino acids 2600−4834) was
ampliﬁed and cloned in the pENTR-D-TOPO vector
(Invitrogen) and recombined into the same lentiviral vector
as the fragments. This lentiviral vector was derived from an
HIV-1-based backbone named “pHAGE”,23 which was
modiﬁed by standard molecular biology techniques to work
as a destination vector for the GATEWAY system (Invitrogen)
and to express an N-terminally tagged protein under the
control of a tetracycline regulatable promoter (TetON). It also
contains a puromycin resistance gene for selection (PHAGE
based vectors expressing HA-tagged proteins). The vectors
created in the Howley lab for expression of HERC2 fragments
are HERC2-F1 (p6325), HERC2-F2 (p6326), HERC2-F3
(p6327), HERC2-F4 (p6328), HERC2-F5 (p6329), HERC2-
F6 (p6330), and HERC2-F456 (p6332). The expression
vectors for genes to be tested as HERC2 interactors were
obtained from the Human ORFeome database (http://horfdb.
dfci.harvard.edu/index.php?page=home) in pDONR and re-
combined into the pHAGE vector described above. These
vectors were used to establish stable cell lines for examination
of their interaction with the endogenous full-length HERC2.
Vectors were created for expression and analysis of HERC2-
interacting proteins for the genes AURKB (p7052), BICD2
(p7053), COPE (p7054), COPZ1 (p7055), CPT1A (p7056),
EIF3E (p7135), EIF3H (p7136), EIF3M (p7137), EME1
(p7140), FDFT1 (p7058), FTH1 (p7126), FTL (p7127),
HLA-A (p7128), HM13 (p7129), KIF20A (p7130), MUS81
(p7141), PHKB (p7138), PHKG2 (p7139), PRKAR2B
(p7133), WDR92 (p7134), and ZFYV9 (p7142). All plasmids
were generated for this study and have been deposited in
Addgene.
Cell Culture and Protein Expression
All cells lines used in this study were maintained in DMEM
10% FBS at 37 °C and 5% CO2. T-REx 293 cells (Invitrogen),
which stably express the Tet repressor (TetON), were
maintained in 5 μg/mL Blasticidin (InvivoGen). After infection
with lentiviruses carrying pHAGE-P CMVt N-HA GAW-
derived vectors, transduced cells were selected with 2 μg/mL
puromycin (Sigma) and maintained after selection in 1 μg/mL
puromycin. To induce the expression of the HA-tagged
proteins, the cells were kept 24 h in medium without
antibiotics and then induced at roughly 80% conﬂuency with
1 μg/mL doxycycline (Sigma) for 24 h. Alternatively, N-HA
tagged protein expression was performed in 293T cells by
transient transfection of 2 μg of plasmid DNA in 6 cm culture
dishes at approximately 50% conﬂuency using TransIT-293
(Mirus) according to the manufacturer’s instructions. Cells
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were harvested 48 h post-transfection for expression and
immunoprecipitation analysis described below.
Immunoprecipitation for MS
HERC2 HA-tagged fragment proteins were immunopuriﬁed,
processed, and analyzed by MS as previously described24 with
modiﬁcations described in Martinez-Noel̈ et al., 2012.22 Brieﬂy,
T-REx cells from ﬁve 15-cm culture dishes (approximately 80−
90% conﬂuent) expressing each HERC2 fragment were washed
once with PBS at room temperature and then lysed on the
plates with 5 mL of ice cold lysis buﬀer (50 mM Tris-HC pH
7.5, 150 mM NaCl, 0.5% NP-40, 12.5 mM NaF, 1 mM
Na3VO4, 12.5 mM β-glycerphosphate, complete protease
inhibitor cocktail (Roche)). Cleared lysates were ﬁltered
through a 0.2 μm SFCA-PF syringe ﬁlter (Corning) and
immunoprecipitated with 50 μL (settled) of anti-HA agarose
beads (Sigma) for 2 h at 4 °C. The beads were then washed
twice with 10 mL of lysis buﬀer and twice with 10 mL of PBS,
transferred with 1 mL PBS into a microfuge tube, and then
eluted with three 50 μL washes of 0.5 N NH4OH, 0.5 mM
EDTA. For IP and Western analysis of HERC2 HCIPs, 293T-
REx (stable) or 293T (transient) cells expressing HA-tagged
proteins were isolated from 6 cm dishes, washed with 1 mL
PBS, lysed with 250 μL lysis buﬀer, and collected in microfuge
tubes. Lysates were pelleted for insoluble material at 13K rpm,
4 °C for 10 min and then immunoprecipitated with 20 μL
(settled) of anti-HA agarose beads for 2 h at 4 °C. Beads were
washed six times with 1 mL of lysis buﬀer, then twice with 500
μL of PBS, and immunoprecipitated protein was eluted with
three 20 μL washes of 0.5 N NH4OH, 0.5 mM EDTA.
MS and Proteomic Analysis
Eluates were TCA-precipitated and subsequently trypsinized in
10% acetonitrile/50 mM ammonium bicarbonate pH 8.
Peptides were acidiﬁed by addition of formic acid to 2.5%,
desalted with Empore C18 extraction media (3 M), and
reconstituted in 10 μL of 5% acetonitrile/5% formic acid. A
total of 2 × 4 μL of peptide mixture was loaded by a Famos
autosampler (LC Packings, San Francisco, CA) onto a 100 μm
(i.d.) × 18 cm fused silica microcapillary column in-house-
packed with C18 reverse-phase resin (Magic C18AQ; 5-μm
particles; 200-Å pore size; Michrom Bioresources, Auburn,
CA), and separated with an Agilent 1100 series binary pump
with in-line ﬂow splitter across a 50 min 8−26% acetonitrile
gradient. Spectra were acquired using an LTQ-Velos linear ion
trap mass spectrometer (Thermo Scientiﬁc, San Jose, CA) with
a data-dependent Top-10 method.25 Each sample was analyzed
twice in succession, followed by a wash with 70% acetonitrile,
30% isopropanol to reduce any potential carry-over. The
resulting spectra were searched using SEQUEST26 against a
target-decoy database of human (UniProt release 2011_05)
tryptic peptides.27 Search parameters included: 2 Da precursor
ion tolerance; up to two missed cleavages; a static modiﬁcation
of 57.0215 Da (carboxyamidomethylation) on cysteine; a
dynamic modiﬁcation of 15.9949 Da (oxidation) on
methionine. Peptides (false discovery rate (FDR) of <1%)
were assembled into proteins accounting for protein redun-
dancy using the principles of parsimony and Occam’s razor
constraints.28 The resulting list of identiﬁcations for each
duplicate run was loaded into CompPASS were the data were
merged and further analyzed.24
Analysis of MS Data Using CompPASS
The IP-MS data were analyzed by CompPASS as previously
described.24,29 We used a stats table with 175 pulldowns from
293 cells generated by the Harper lab. The WD score threshold
was calculated in a way that 95% of the data falls below it. The
normalized WD (NWD) score results from dividing each WD
score by the calculated threshold. We considered HCIPs those
proteins with a NWD score equal to or higher than 1 (WD
score equal to or higher than the calculated threshold). We did
not use a peptide cutoﬀ number for the CompPASS analysis;
the number of peptides for each interacting protein is listed in
the Supplemental Tables, Supporting Information.
Western Blot Analysis
Protein extracts were prepared using the lysis buﬀer described
above. Immunoprecipitations from 293T-REx or 293T cells
analyzed by Western blot were prepared following elution with
0.5 N NH4OH, 0.5 mM EDTA by incubating 20 μL of eluate
(one-third of the immunoprecipitated material) in gel loading
buﬀer at 65 °C, followed by SDS-PAGE and electroblotting to
PVDF. Blots were blocked with 5% nonfat dried milk in TNET
(10 mM Tris-HCl pH 7.5, 150 mM NaCl, 2.5 mM EDTA, and
0.1% Tween 20) and then incubated with the following primary
antibodies: HA conjugated to HRP (clone 3F10, Roche), E6AP
(Clone E6AP-300, Sigma), HERC2 (BD Transduction
Laboratories), MAPK6 (ERK3, Cell Signaling), NEURL4
(ProteinExpress), and actin (Millipore.). Except when the
HA-HRP antibody was used, the membranes were washed in
TNET and incubated with HRP-conjugated antimouse or
antirabbit secondary antibodies (GE Healthcare). Signals were
generated using Western Lightning chemiluminescent substrate
(PerkinElmer) and recorded on BioMax MR ﬁlms (Kodak).
Bioinformatic Analysis
The Genomatix Pathway System (GePS, www.genomatix.de)
was used to create biological knowledge-based HERC2
networks as previously described.30 Brieﬂy, functional enrich-
ment analysis of the HERC2 gene set was performed with the
FuncAssociate algorithm31 as implemented in the Genomatix’
GeneRanker module. GeneRanker assesses functional enrich-
ment with a Fisher’s Exact Test and then estimates an adjusted
p-value via 1000 simulated null hypotheses. Gene Ontology and
Pathway Data were collected from the Gene Ontology and NCI
Pathway Interaction Databases32,33 and the Memorial Sloan-
Kettering Cancer Center’s Cancer Cell Map.34 The basal
pathway and network data were supplemented with informa-
tion obtained from Genomatix’ LitInspector35 and MatBase,36
UniProt,37 DBSubLoc,38 STITCH,39 Gene Expression Atlas,40
Reactome,41 and ENCODE.42 Nodes were color-coded
according to NWD score with the median score 2.12.
Immunoﬂuorescence and Microscopy
293 T-REx cells grown on 12 mm glass coverslips were washed
twice with PBS and ﬁxed in 4% formaldehyde (Sigma) for 15−
20 min. Coverslips were then washed twice with PBS and
permeabilized for 5 min in buﬀer containing PBS, 1% BSA, 5%
normal goat serum, and 0.5% Triton X-100 (Sigma) followed
by incubation in permeabilization buﬀer containing primary
antibody for 1 h. Primary antibodies were used for staining
HERC2 (BD Transduction Laboratories, 1 μg/mL, mouse) and
HA (Abcam, 2 μg/mL, rabbit). Coverslips were then washed
four times in PBS and incubated in permeabilization buﬀer
containing secondary antibody for 1 h. Secondary antibodies
used were goat antirabbit or antimouse conjugated to Alexa 594
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(Molecular Probes, 1:500), goat antirabbit conjugated to Alexa
488 (Molecular Probes, 1:500), or goat antimouse conjugated
to Alexa 488 (Abcam, 1:500). Controls for HA-speciﬁcity
included cells expressing HA-EIF3E probed with antirabbit
IgG, or cells not expressing HA-EIF3E probed with anti-HA
antibody. Coverslips were then washed four times in PBS and
either mounted onto glass microscope slides with SlowFade
Gold +DAPI (Invitrogen) for single protein stain, or for
sequential staining for colocalization, incubated in primary and
secondary antibodies as described above, and then mounted.
Coverslips were secured to slides with nailpolish. All steps were
performed at room temperature. For immunoﬂuorescence,
coverslips on slides were visualized with an Olympus Fluoview
FV1000 IX81 inverted confocal microscope with motorized
stage. Images were acquired using a PLAPON 60X O/1.42 NA
oil immersion objective and FV10-ASW 3.1 software. Images
were generated from nonoverlapping emission spectra at 1024
× 1024 pixel (12 bit/pixel) resolution. The software was used
to overlay two images generated from 405, 488, and 594 nm
lasers.
■ RESULTS
Proteomic Identiﬁcation of HERC2-Interacting Proteins
To gain further insight into the various cellular functions of
HERC2, we conducted a proteomic analysis of HERC2-
interacting proteins. HERC2 is a large protein with multiple
domains, some of which have been shown to interact with
speciﬁc cellular proteins (Figure 1A). Since the full-length
HERC2 protein proved diﬃcult to stably express at a suﬃcient
level for MS analysis, six overlapping fragments comprising the
complete HERC2 ORF were expressed. Each fragment,
approximately 1000 amino acids in length (F1−F6, Figure
1A), was stably expressed in tetracycline-inducible HEK 293
cells (T-REx 293, Invitrogen) with an amino-terminal HA tag
(N-HA) for immunoprecipitation (Figure 1B). Proteins
coprecipitating with each HERC2 fragment were identiﬁed by
LC−MS-MS, and a list of high conﬁdence interacting proteins
(HCIPs) was generated by CompPASS analysis.24 HA-tagged
GFP served as a negative control. Our analysis identiﬁed
NEURL4 and UBE3A as HCIPs for F1 and F4, respectively.
Each of these proteins has previously been identiﬁed as a
HERC2-interacting protein, thus providing validation for our
studies.17,21
Table 1 displays a list of proteins identiﬁed as HCIPs for
each fragment. Proteins analyzed by CompPASS were
considered HCIPs by meeting the statistical threshold cutoﬀ
of 0.95 and a calculated normalized weighted D-score (NWD)
of 1.0 or greater. The top 25 HCIPs for each fragment are listed
in Table 1 (complete results are in Supplementary Table S1,
Supporting Information). Overall, 283 potential interactors
were identiﬁed, 239 of which were identiﬁed in the analysis of
only a single fragment. The remaining 44 HCIPs were
identiﬁed in the analysis of two (30 HCIPs), three (10
HCIPs), four (3 HCIPs), or ﬁve (1 HCIP) diﬀerent fragments.
HCIP identiﬁcation with more than one fragment could
potentially be due to fragment overlap with the site of HCIP
interaction, a complex interaction between two or more
proteins interacting with diﬀerent regions of HERC2, or from
a stable but nonspeciﬁc interaction. Overall, more than 80% of
the HCIPs identiﬁed in our analysis were found to interact with
a single fragment of HERC2.
F1 of HERC2 contains a single RLD domain and yielded 133
HCIPs, 103 of which were unique to F1. The RLD1 of HERC2
is deﬁned by high homology to RCC1, a protein that functions
as a guanine nucleotide-exchange factor (GEF) promoting the
release of GDP and uptake of GTP by the G protein Ran, and
is important in cell division and mitosis.43,44 The Rho GEF
ARHGEF5 and the GTPase-activating protein AGAP3 were
among the HCIPs identiﬁed with F1, in addition to KIF20A, a
kinesin known to interact with GTP-bound Ras family
members RAB6A and RAB6B.45,46 These ﬁndings are
signiﬁcant as multiple proteins serve to link HERC2 with G
protein activity and regulation.
HERC2 has been previously implicated in genomic repair,7,10
and among the HCIPs identiﬁed with F1 were EME1 and
MUS81, components of an endonuclease heterodimer active in
the repair of structure-speciﬁc DNA nicks at Holliday junctions,
3′-ﬂaps, and stalled replication forks.47,48 HERC2 has been
found at stalled replication forks;12 however, EME1 and
MUS81 have not previously been identiﬁed as HERC2
interactors. Another interactor, the coiled-coil domain contain-
ing 22 protein (CCDC22), is involved in NF-κB regulation
through its interaction with COMMD proteins.49 COMMD
proteins contribute to the ubiquitylation of the NF-κB subunit
Figure 1. HERC2 schematic and fragment expression. (A) The
HERC2 open reading frame encodes a 4834 amino acid polypeptide
containing three RCC1-like domains (RLD) and a carboxy terminal
HECT domain found in a class of ubiquitin ligases. Additional
domains share homology to cytochrome b5 (Cyt-b5), zinc ﬁnger (ZF)
and two other ubiquitin ligases (MIB and DOC). HERC2 binding
sites with known interactors are shown above, and the region of each
HERC2 fragment expressed for proteomic analysis is shown below the
corresponding HERC2 sequence (F1−F6). (B) The HERC2 open
reading frame was expressed as six separate overlapping fragments
under control of a tetracyclin-responsive element and stably
transfected into 293 T-REx cells (Invitrogen). Treatment with 1 μg/
mL doxycycline for 24 h resulted in HERC2 fragment expression of
the expected size (major band in “Dox +” lanes). Size markers in
kilodaltons are on the left.
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RELA, leading to its degradation, and thereby down-regulating
NF-κB activity.50 COMMD1, COMMD3, COMMD4, and
COMMD8 were also identiﬁed as HCIPs in the F1 analysis,
suggesting a complex interaction with HERC2 and CCDC22.
Fifteen HCIPs were identiﬁed in the analysis of F2, eight of
which were unique to F2. Although this is a low number of
HCIPs relative to other fragments, several of these proteins
share important cellular functions. SPTLC2 and ASAH1 are
enzymes critical to sphingolipid biosynthesis and degradation,
respectively.51,52 ASAH1 is a lysosomal enzyme and cathepsin
A (CTSA), another HCIP, is a serine protease found in the
lysosome.53 In general, cathepsins are responsible for several
physiological processes, the most well-known being protein
turnover in the lysosome.54 Three diﬀerent proteins involved in
immune function were identiﬁed as HCIPs. The mitochondrial
antiviral signaling protein (MAVS) is necessary for tran-
scription factor activation regulating beta interferon expression
in the innate immune response.55 The histocompatibility minor
protein 13 (HM13) and major complex class I A protein (HLA-
A) are involved in signal peptide processing and antigen
presentation, respectively.56,57 HLA-A was also found as an
HCIP of F1, along with MHC class I proteins HLA-C and
HLA-E, which were also identiﬁed with HM13 as HCIPs in the
analysis of F3. The identiﬁcation of these HLA proteins by
separate fragments with diﬀerent functional domains all within
the amino terminal half of HERC2 suggests this region of
HERC2 may have some role in immune functions through
interaction with multiple HLA proteins.
The pulldown and CompPASS analysis of F3 of HERC2
resulted in the identiﬁcation of 52 proteins, 35 of which were
only recognized with F3. Among the unique F3 HCIPs were
seven subunits of the COPI coatomer protein complex (COPA,
COPB1, COPB2, COPE, COPG1, COPG2, and COPZ1)
involved in vesicle-mediated Golgi to ER protein transport.58
Five of these COPI proteins are known to interact with
TMED10, a transmembrane protein important for COPI
vesicle formation, also found as an HCIP in the analysis of
F3. Other HCIPs for this fragment include the ferritin heavy
and light chains (FTH1, FTL) and the nuclear receptor
coactivator 4 (NCOA4), the latter of which was recently
reported to bind and regulate ferritin transport during
autophagy.59
F4 of HERC2 contains the sequence previously shown to
interact with the ubiquitin ligase UBE3A.21 This was conﬁrmed
in our analysis as UBE3A was one of 30 unique HCIPs (48
total) found to interact with F4. Multiple HCIPs found with F4
are also reported to bind UBE3A, including glutamate
dehydrogenase (GLUD1), a metallochaperone involved in
cytochrome c oxidase biogenesis, SCO2, and the centrosomal
protein CEP170. Additional F4 HCIPs include BICD1 and
BICD2, as well as the zinc ﬁnger and FYVE domain-containing
protein ZFYVE9 (also known as SARA). BICD1 and BICD2
are proteins involved in the motility of membrane-bound
organelles regulating their transport.60 ZFYVE9 was originally
identiﬁed as an anchor for SMAD2 and SMAD3 activation, and
general regulator of TGF-β signaling.61 More recently, ZFYVE9
has been implicated in cellular traﬃcking due to its localization
to the endosome62 and reported interactions with the GEF Rab
563 and vesicle mediator syntaxin-3.64
Table 1. HERC2 Fragment MS Analysis and HCIP Identiﬁcationa
F1 1−1000 F2 950−1750 F3 1700−2700 F4 2600−3600 F5 3550−4500 F6 4421−4834
Gene NWD Gene NWD Gene NWD Gene NWD Gene NWD Gene NWD
MUS81 4.24 ASAH1 6 ITPR2 8.49 BICD1 14.7 PHKA2 7.75 LCP1 18
CCDC22 4.24 MAVS 3.5 PTPN1 8.49 BICD2 14 ENPP1 6.93 SELO 15
AGAP3 4.24 CST4 3 GNA13 8.49 ZFYVE9 12.37 EIF3H 6.12 SPECC1L 10.39
ARHGEF5 3.97 SPTLC2 2.42 FNDC3A 6 CEP170 11.64 MIOS 5.66 SNX6 10.39
EME1 3.35 ZG16B 2.27 EPCAM 5.2 SNAPIN 8.49 PHKB 5.41 ARAF 10.39
HERC1 3.35 NCCRP1 2 NCOA4 4.08 UBE3A 6.39 EIF3A 5.33 TUBB3 8.16
KIF20A 3.18 HLA-A 1.98 MAVS 3 SLC30A9 6 PHKG2 5.29 RAF1 6.89
HPS3 3 HM13 1.75 LACTB 3 PCM1 5.29 OCRL 5.2 ABR 6.09
HPS5 2.12 VDAC2 1.75 NEK11 2.83 FHOD3 5.2 MTMR3 5.2 RER1 6
TUBA1C 2.1 KRT80 1.6 HLA-E 2.83 AKAP9 4.9 EIF3E 4.78 TXLNG 6
MLL4 2 CSTA 1.5 LMNB2 2 NIN 4.41 PHKA1 4.74 CBX2 6
RAB34 2 BLMH 1.21 TUBA1C 1.77 NUDCD2 4.24 WDR59 4.58 PRR14L 3
NEURL4 1.98 PSMB4 1.03 FTH1 1.73 SLC27A4 3.67 EIF3B 4.38 SENP1 3
ZDHHC17 1.73 PSMD1 1.11 MLEC 1.7 ASPM 3.46 EIF3L 4.04 ATP4A 3
EPHA7 1.73 PSMD11 1.02 PSMD1 1.66 PEX1 3.46 EIF3M 3.96 EXD2 2.83
ZBTB5 1.7 PELP1 1 LMNA 1.56 USP20 3.32 EIF4G1 3.81 SSX2IP 2.83
NUP153 1.7 TEX10 1 HM13 1.5 ETAA1 3 EIF3G 3.75 TUBA1C 2.83
GTF3C2 1.7 BIRC6 1.5 PRR14L 3 EIF3C 3.74 RNGTT 2.64
MLF2 1.7 C19orf2 1.5 RIC8A 3 EIF3K 3.47 CDC25C 2.12
ARNT 1.67 PPM1B 1.5 PHKG2 2.83 EIF3D 3.19 MYO9B 2.12
RNGTT 1.5 COPB2 1.37 SCO2 2.83 CTNNA1 3 SLC27A4 2.12
C10orf118 1.5 OBSL1 1.33 WDR62 2.6 CTNNB1 2.83 CXorf57 2.12
TRMT2A 1.5 COPG2 1.31 GNAS 2.6 WDR24 2.3 KIAA0889 2.12
VSIG7 1.5 COPG 1.29 TUBA1C 2.19 EIF3I 2.26 FLII 2.08
FDFT1 1.34 COPA 1.25 PHKB 2.12 GCC2 2.22 FASTKD5 2
aThe 25 highest scoring HERC2 interactors for each fragment following immunoprecipitation, mass spectrometry, and CompPASS. The scores for
each HCIP were generated at a 0.95 conﬁdence threshold. The genes in bold indicate HCIPs with NWD ≥ 1 when using a 0.98 threshold. Genes in
italics were identiﬁed as an HCIP with more than one HERC2 fragment.
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Thirty-seven proteins were identiﬁed as HCIPs in the
analysis of F5, 27 of which were unique to this fragment. Most
signiﬁcant among the 27 unique F5 HCIPs were 12
components of the eukaryotic translation initiation factor 3
complex (eIF3). The eIF3 scaﬀold is the largest initiation
complex formed during cellular protein translation and serves
multiple distinct functions including the facilitation of mRNA
and ribosomal binding, large and small ribosomal subunit
dissociation, and stabilization of the eIF2-GTP-Met-tRNAi
complex, as well as interacting with several diﬀerent initiation
factors.65 Also identiﬁed in the F5 analysis were all three
regulatory subunits (PHKA1, PHKA2, and PHKB) and one
catalytic subunit (PHKG2) of phosphorylase kinase (PhK), a
serine/threonine kinase involved in glycogen metabolism.66
F6 is the shortest of all the HERC2 fragments and contains
the carboxy-terminal HECT domain responsible for ubiquitin
ligase activity. Forty-eight proteins were identiﬁed as HCIPs, 32
of which were identiﬁed only with F6. There is an important
diversity among the function of the F6 HCIPs, but most
proteins possess known roles in microtubule-based binding and
vesicle-mediated traﬃcking (LCP1, SPECC1L, MYO9B, FLII,
TUBA1C, TUBB3, SNX6, RER1, TXLNG, IQGAP1,
LRPPRC), cellular growth signaling (ARAF, RAF1,
CDC25C), and various mechanisms governing cellular tran-
scription and translation (VBP1, PFDN4, PFDN5, PFDN6,
RPS27L, RNGTT, CBX2, GCN1L1, XPOT). The interaction
of these proteins with F6 of HERC2 is also important due to
the nature of the HERC2 HECT domain, contained within this
fragment, and the possibility that these proteins may serve to
regulate HERC2 ubiquitin ligase activity or may be substrates
for HERC2-mediated ubiquitylation. Our analysis greatly
expands the HERC2−protein interactome, providing numerous
potential HERC2 regulators and substrates, and implicating
HERC2 in several important cellular processes.
HCIP Analysis Links HERC2 to Intracellular Traﬃcking and
Energy Metabolism
Our proteomic analysis identiﬁed 283 distinct HERC2 HCIPs,
the majority of which have not been previously reported. To
probe the potential cellular functions of HERC2 more deeply,
functional enrichment of gene ontology (GO) biological
process (BP) terms and subsequent biological network analyses
of the HERC2 HCIP gene list were performed using
Genomatix Pathway System (GePS, http://mygga.genomatix.
de/). The highest NWD score for each HCIP (if identiﬁed in
multiple experiments) was used to color code the correspond-
ing gene node in the interaction networks generated for each
GO BP term. Two hundred seventy-one signiﬁcantly enriched
terms were identiﬁed in our analysis. Given the high degree of
gene redundancy among GO deﬁnitions, functionally enriched
GO BP terms were grouped by distinct function using a
Figure 2. Intracellular transport pathways involving HERC2. GePS analysis of HERC2 HCIPs yielded 15 distinct GO biological process terms
related to various intracellular protein transport and traﬃcking pathways (Table 2). Forty HERC2-interacting genes were represented, 27 of which
comprise the major network shown in (B). Network HCIPs and the corresponding HERC2 fragment used for identiﬁcation are displayed in (A).
The GTPase RAB2A is linked to the COPI coatomer complex and beta-catenin, the latter of which integrates PI3K signaling with other subnetworks
involving vesicle-mediated transport and localization. Nodes are colored according to the gene’s NWD score from the HERC2 CompPASS analysis.
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combination of term similarity and percentage of input genes
representing the total number of genes associated with a term.
This proved useful in distilling the large number of GO terms
and identifying potential cellular pathways in which HERC2
may be involved.
HERC2 HCIP GePS analysis revealed 15 functionally
enriched GO BP terms involving intracellular vesicle-mediated
organization and transport. A nonredundant gene interaction
network was generated encompassing all input genes associated
with vesicle-mediated transport-related GO BP terms (Figure
2). Of the 40 HERC2 HCIPs associated with the 15 enriched
GO BP terms, 27 HCIPs have a known biological relationship,
which is depicted in the network in Figure 2. The GePS builds
interaction networks from known biological data, which include
expertly curated and experimentally validated associations,
combined with natural language processing of PubMed
abstracts. Consequently, the edges between nodes represents
the association between two or more genes as deﬁned by one of
the methods described above. The 13 HCIPs not displayed in
the interaction network had no known association with any of
the genes involved in the network or with each other (unlinked
genes).
The major network shown in Figure 2 contains all subunits
of the COPI coatomer complex involved in retrograde Golgi-
ER transport (ARCN1, COPA, COPB1, COPB2, COPE,
COPG1, COPG2, COPZ1). This complex is linked to the Rab
GTPase family member RAB2A. The COPI complex and Rab
signaling represent vesicular traﬃcking and transport pathways
that are integrated in this network through beta-catenin
(CTNNB1), a component of adherens junctions necessary
for anchoring the actin cytoskeleton, as well as being a core
member of the Wnt signaling pathway.67 Beta-catenin addi-
tionally links lipid kinase signaling (PI3KR1), and calcium and
iron regulation (CALCA and FTH1/FTL, respectively), with
these transport pathways and implicates HERC2 in the
coordination of intracellular protein transport.
Several proteins identiﬁed as potential HERC2 interactors
were associated with cellular processes involved in the
production and metabolism of cellular energy. Using GePS,
14 functionally enriched GO BP terms were identiﬁed
containing 19 HERC2 HCIPs. Of these 19 HCIPs, nine were
linked in the original combined network (original network not
shown). We then used GePS to extend all 19 HCIPs by known
associations with other HCIPs not produced in the enrichment
analysis. This extension added 13 HCIPs through known
associations with the nine HCIPs from the original network and
four of the previously unlinked genes, totaling 26 HCIPs. All 26
linked HCIPs were reconﬁgured to generate the interaction
network displayed in Figure 3.
The central nodes represent proteins involved in energy and
metabolite production in the mitochondria (SLC25A4,
SLC25A10, TOM22, IMMT, SCO2). These are integrated
into the network by the outer ring through known associations
to proteins involved in fatty acid metabolism (CPT1A), and the
regulation of antioxidants (via GPX1) and insulin (via PTPN1).
Other HCIPs composing the outer ring of the network are
involved in the generation and transport of fatty acids
(SLC27A2, SLC27A4, FDFT1), iron homeostasis (FTH1 and
FTL), and insulin metabolism (PIK3R1 and ENPP1). Addi-
tional subnetworks include the components of the glycogen
regulator phosphorylase kinase (PHKA1, PHKA2, PHKB,
PHKG2) and the establishment of proton gradients and
electron transport in the cell (ATP5J, NDUFA11, ATP6 V1A).
Overall, the association of multiple HERC2 HCIPs important
to the regulation of insulin, glycogen, and fatty acid generation
and transport, support a role for HERC2 as a component of
pathways governing the metabolism and maintenance of
cellular energy.
Validation of HERC2-Interacting Proteins
We next attempted to validate the interaction of endogenous
HERC2 with HCIPs identiﬁed in our MS/CompPASS analysis.
To do so, potential interactors were expressed as N-HA
proteins in 293T-REx cells and analyzed for their interaction
with full-length endogenous HERC2 using an antibody to
HERC2 (Figure 4). Available expression vectors were selected
from the Human ORFeome Database and cloned into vectors
containing an N-HA tag. Variable levels of expression were
observed following transient transfection, but full-length
protein could generally be detected following HA-immunopre-
cipitation (Figure 4). Binding to endogenous HERC2 was
analyzed by Western blot with HA-GFP serving as a negative
control. We examined a total of 21 cellular proteins identiﬁed in
Table 2. GO Biological Process Terms Associated with HERC2 HCIPs Related to Intracellular Vesicle-Mediated Organization
and Transporta
GO-Term GO-Term ID p-value Adj p-value # input genes # total genes
retrograde vesicle-mediated transport, Golgi to ER GO: 0006890 3.41 × 10−12 0.00 × 100 10 25
COPI-coated vesicle budding GO: 0035964 6.07 × 10−12 0.00 × 100 8 13
Golgi transport vesicle coating GO: 0048200 6.07 × 10−12 0.00 × 100 8 13
COPI coating of Golgi vesicle GO: 0048205 6.07 × 10−12 0.00 × 100 8 13
Golgi vesicle budding GO: 0048194 1.40 × 10−11 0.00 × 100 8 14
vesicle targeting to, from, or within Golgi GO: 0048199 2.94 × 10−10 0.00 × 100 9 27
vesicle targeting GO: 0006903 8.71 × 10−9 0.00 × 100 9 38
vesicle coating GO: 0006901 1.12 × 10−8 0.00 × 100 9 39
Golgi vesicle transport GO: 0048193 2.07 × 10−8 0.00 × 100 17 192
vesicle organization GO: 0016050 3.29 × 10−8 0.00 × 100 13 110
vesicle-mediated transport GO: 0016192 2.19 × 10−7 0.00 × 100 40 1010
establishment of vesicle localization GO: 0051650 4.15 × 10−6 0.00 × 100 11 118
intra-Golgi vesicle-mediated transport GO: 0006891 1.01 × 10−5 0.00 × 100 6 31
vesicle localization GO: 0051648 2.96 × 10−5 0.00 × 100 11 145
Golgi localization GO: 0051645 7.17 × 10−3 1.00 × 10−2 2 8
aFifteen gene ontology biological process terms with a p-value ≤ 0.05 used to generate the network shown in Figure 2. The number of HERC2
HCIPs (Input Genes) associated with each GO term and total number of genes associated with each term are listed.
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our proteomic analysis above as potential HERC2 interactors
(19 HCIPs) and were able to conﬁrm binding of 13 to
endogenous HERC2. This validation provides a level of
conﬁdence for the many other HERC2 HCIPs revealed by
the CompPASS analysis above.
Of the proteins examined, the cellular transport adaptor
BICD2 and the endosomal protein ZFYVE9 coprecipitated the
greatest amount of HERC2, though each bait protein was also
expressed at a very high level (Figure 4). We corroborated the
HERC2-ZFYVE9 interaction by a reciprocal MS-CompPASS
analysis and identiﬁed HERC2 as an HCIP of ZFYVE9 (data
not shown). The mitotic kinesin KIF20A also coprecipitated a
modest amount of HERC2. When analyzed by NWD score,
BICD2 and ZFYVE9 were among the top three HCIPs for F4,
and KIF20A was among the highest for F1 (Table 1). ZFYVE9
and KIF20A were among the HCIPs linking HERC2 with
intracellular transport (Figure 2). BICD2 is known to regulate
Golgi-ER transport, and its paralogue BICD1 was also
associated with HERC2-linked intracellular transport. The
strong interaction between HERC2 and BICD2, ZYFVE9 and
KIF20A, provides additional support for a potential role of
HERC2 in intracellular protein traﬃcking and transport.
Intracellular iron storage is mediated by the protein ferritin,
which is composed of heavy (FTH1) and light (FTL) subunit
chains. Both the FTH1 and FTL subunits were identiﬁed as
HCIPs with F3, and each displayed an interaction with
endogenous HERC2 (Figure 4A). Responsible for regulating
iron storage and transport, ferritin is a component in the major
Figure 3. Cellular energy and metabolism pathways involving HERC2. GePS analysis of HERC2 HCIPs yielded 14 distinct GO biological process
terms regarding processes involved in energy and cellular metabolism (Table 3). Nineteen HERC2-interacting genes were represented, 10 of which
were not linked in any network. Four of the unlinked genes (ENPP1, ITPR2, ARNT, SCO2) and all other linked genes were extended by known
interactions to other input genes and reorganized to generate the major network shown in B. Network HCIPs and the corresponding HERC2
fragment used for identiﬁcation are displayed in A (ﬁve HCIPs were identiﬁed with more than one fragment). Nodes are colored according to the
gene’s NWD score from the HERC2 CompPASS analysis.
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networks linking HERC2 with intracellular protein transport
and cellular energy metabolism (Figures 2 and 3). NCOA4 is
important for mediating the autophagic turnover of ferritin,59
and while our results show an interaction between HERC2 and
FTH1/FTL, we cannot rule out that the interaction is a
consequence of overexpression and is indirect via the known
interaction of NCOA4 with ferritin.
Among the proteins linking HERC2 with cellular energy
metabolism (Figure 3), the PHKB and PHKG2 subunits of
PhK were examined for binding endogenous HERC2. Despite
good protein expression, only the PHKB subunit bound an
appreciable amount of full-length HERC2 (Figure 4B). FDFT1,
an important enzyme for the synthesis of cholesterol, was
identiﬁed as an HCIP associated with F3 and is a component of
the cellular energy metabolism pathways linked to HERC2
(Figure 3). FDFT1 was found to interact with endogenous
HERC2 (Figure 4A), and along with PHKB, supports a role for
HERC2 in the regulation of cellular energy.
Twelve subunits of eIF3 were identiﬁed as F5 HCIPs (Table
1), and we examined the interaction of three diﬀerent
components of this complex (EIF3E, EIF3H, EIF3M) with
HERC2. Each eIF3 subunit coprecipitated endogenous HERC2
to a similar degree suggesting a highly stable complex
interaction (Figure 4B). We corroborated the eIF3−HERC2
interaction by a reciprocal MS-CompPASS analysis of EIF3E,
and identiﬁed HERC2 as an HCIP of EIF3E (data not shown).
We further validated the interaction between HERC2 and eIF3
by confocal miscroscopy in cells expressing HA-tagged EIF3E.
Figure 5 depicts three diﬀerent ﬁelds that demonstrated
endogenous HERC2 and EIF3E to be cytoplasmic; partial
colocalization is revealed by the yellow and orange cytoplasmic
dots evident in the image overlays. The validation of HERC2
interaction with multiple members of the eIF3 complex also
suggests a role for HERC2 in the regulation of cellular protein
expression through translational initiation.
HERC2 is known to be important for maintenance of
genomic integrity and the response to DNA damage through
interactions with several DNA repair proteins. In the
CompPASS analysis of HERC2 HCIPs, we identiﬁed EME1
and MUS81, a heterodimeric endonuclease complex that
resolves structure-speciﬁc DNA lesions.47 We validated the
interaction of HERC2 with EME1 (Figure 4B), but not
MUS81, suggesting that HERC2 interacts with this complex
directly through EME1 (analysis of nonbinders is provided in
the Discussion). Nonetheless, this ﬁnding supports the role of
HERC2 in DNA damage and repair, potentially placing it in a
new context.
The NWD score utilized for identiﬁcation of HCIPs is a
metric combining multiple factors that provides a level of
conﬁdence to potential bait−prey interactions. The capture and
identiﬁcation of proteins is impacted by, among other things,
the amount of prey protein and the stability of the interaction.
Since transient interactions and/or those with proteins of low
abundance could be extremely important but produce a low
NWD score, we also reviewed NWD scores for each fragment
at less stringent conﬁdence thresholds and examined AURKB
and PRKAR2B for interaction with endogenous HERC2.
AURKB, a serine/threonine kinase involved in regulation of
chromosome alignment and mobility,68 displayed modest
binding to endogenous HERC2 (Figure 4A). Identiﬁed in
multiple analyses of F1, AURKB interacts with the same region
of HERC2 as NEURL4, the latter of which cooperates with
HERC2 in centrosome maintenance, a process that may also
involve AURKB. Among several proteins involved in lipid and
glucose metabolism, we validated HERC2 binding with the
regulatory subunit of protein kinase A PRKAR2B (Figure 4A).
PRKAR2B was identiﬁed in the analysis of F4, along with two
of the PhK subunits, implicating HERC2 in the regulation of
cellular energy metabolism through multiple pathways and
complexes.
Overall, our analysis has provided a wealth of new
information regarding HERC2 protein interactions in the cell.
We’ve identiﬁed numerous potential HERC2 binders that
participate in diverse and functionally important cellular
processes. We have conﬁrmed the in vivo interaction between
HERC2 and over a dozen HCIPs, implicating HERC2 in
previously unlinked pathways and imparted a source of study
that promises to enhance our understanding of several
mechanisms vital to the cell.
■ DISCUSSION
HERC2 is a large ubiquitin ligase with known roles in enzyme
regulation, the maintenance of centrosome architecture, and
the cellular response to DNA damage. Despite its size and the
diversity of cellular processes in which HERC2 is reportedly
involved, relatively few proteins have been shown to interact
Table 3. GO Biological Process Terms Associated with HERC2 HCIPs Related to Cellular Energy and Metabolisma
GO-Term GO-Term ID p-value Adj p-value # input genes # total genes
cellular carbohydrate catabolic process GO: 0044275 2.86 × 10−4 0.00 × 100 6 55
glycogen catabolic process GO: 0005980 6.02 × 10−4 1.00 × 10−3 4 24
glucan catabolic process GO: 0009251 7.07 × 10−4 1.00 × 10−3 4 25
cellular polysaccharide catabolic process GO: 0044247 7.07 × 10−4 1.00 × 10−3 4 25
energy derivation by oxidation of organic compounds GO: 0015980 8.20 × 10−4 1.00 × 10−3 14 316
polysaccharide catabolic process GO: 0000272 9.56 × 10−4 1.00 × 10−03 4 27
energy reserve metabolic process GO: 0006112 1.59 × 10−3 1.00 × 10−3 9 163
generation of precursor metabolites and energy GO: 0006091 2.72 × 10−3 5.00 × 10−3 16 439
glucose metabolic process GO: 0006006 3.27 × 10−3 4.00 × 10−3 10 216
polysaccharide metabolic process GO: 0005976 4.96 × 10−3 4.00 × 10−3 6 95
glycogen metabolic process GO: 0005977 5.02 × 10−3 2.00 × 10−3 5 67
glucan metabolic process GO: 0044042 5.35 × 10−3 3.00 × 10−3 5 68
cellular glucan metabolic process GO: 0006073 5.35 × 10−3 3.00 × 10−3 5 68
hexose metabolic process GO: 0019318 9.43 × 10−3 8.00 × 10−3 10 252
aFourteen gene ontology biological process terms with a p-value ≤ 0.05 used to generate the network shown in Figure 3. The number of HERC2
HCIPs (Input Genes) associated with each GO term and total number of genes associated with each term are listed.
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directly with HERC2, while the mechanism of HERC2 function
in the cell remains largely unknown. In this study, we utilized a
systematic proteomic approach to identify HERC2-interacting
proteins and utilized bioinformatics tools to provide context for
the interactions, yielding greater insight into HERC2 cellular
functions.
Our proteomic analysis of stable HERC2 protein interactions
utilizing CompPASS identiﬁed over 280 HCIPs. Among these
interactors were components of cellular protein complexes
involved in vesicle-mediated transport (COPI coatomer
complex), glycogen metabolism (phosphorylase kinase), and
the regulation of cellular protein translation (eIF3 complex).
The large number of HCIPs and the heterogeneity of their
known cellular functions led us to analyze HERC2 HCIPs using
the Genomatix Pathway System. Over 270 functionally
enriched GO BP terms were grouped to generate potential
HERC2 interaction networks of distinct cellular functions,
identifying pathways regulating intracellular protein transport
and traﬃcking (Figure 2), metabolism of cellular energy
(Figure 3), and cellular protein translation. A dozen or more
HERC2 HCIPs were involved in each of these processes, which
provide links to potential HERC2 functions that have not been
previously described.
To support the involvement of HERC2 in these pathways,
we validated the interaction of various HCIPs with the full-
length endogenous HERC2 protein (Figure 4). We were able
to conﬁrm binding of HERC2 with genes linked in each
network, including FDFT1 and PHKB (energy), ZFYVE9
Figure 4. Validation of HERC2 HCIPs. HERC2 HCIPs were transiently expressed as N-HA tagged proteins in 293T cells (A) or stably transfected
in 293T-REx cells and expressed following induction with 1 μg/mL doxycycline (B). Expressed proteins were immunoprecipitated (HA-IP) from
equivalent amounts of total cellular protein. Variable levels of expression were seen for each protein (Input, middle panel) and the expressed protein
was appropriately puriﬁed (HA-IP, middle panel). Protein interaction with HERC2 was examined by Western blot for endogenous full-length
HERC2 (HA-IP, top panel). Size markers in kilodaltons are on the left. Gene symbol and NWD score of proteins examined for binding endogenous
HERC2 are displayed in the table.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr501005v | J. Proteome Res. 2015, 14, 953−966962
(traﬃcking), and FTH1 and FTL (both networks). HCIPs not
found to bind HERC2 in our coprecipitation studies often
represented one subunit of a complex whose other members
displayed stronger HERC2 binding. For example, the PhK
catalytic subunit PHKG2 and the DNA repair endonuclease
component MUS81 did not coprecipitate with HERC2 and
thus may bind HERC2 indirectly through other complex
members, such as PHKB and EME1, respectively. Alternatively,
the inability of a protein to coprecipitate HERC2 may be
because the N-HA tag, placed on the HCIP instead of a
HERC2 fragment, may interfere with the HERC2-HCIP
interaction. The method of detecting an interaction may also
be an issue as mass spectrometry is much more sensitive than
Western blot, oﬀering the possibility that the amount of HCIP
bound to HERC2 was a limiting factor in the validation.
Among the most interesting ﬁndings, several HCIPs involved
in cellular protein translation were identiﬁed, including the eIF3
complex, the eIF4 complex subunit G1, and four members of
the prefoldin family of proteins. Prefoldins are known for
regulating chaperone-mediated folding of ﬁlament proteins,
such as actin and tubulin, and were recently reported to be
involved in transcriptional elongation.69,70 GePS analysis did
not reveal any signiﬁcant association among eIF3 and prefoldin
members; however the large size of HERC2 and identiﬁcation
of eIF3 and prefoldins by adjacent HERC2 fragments with 80
amino acids of overlap suggest that HERC2 could serve to
structurally bridge translation initiation and protein folding by
these complexes. As prefoldins assist in the folding of proteins
bound for the cytoskeleton, their association with HERC2 also
strengthens the potential for HERC2 function in intracellular
traﬃcking and transport pathways.
Regarding an alternative potential role for HERC2 in
translation, the HPV E6 oncoprotein has been reported to
stimulate the mammalian target of rapamycin complex 1
(mTORC1) and cap-dependent translation, a phenomenon
enhanced by E6 interaction with E6AP.71,72 Since HERC2
interacts with E6AP-bound to E6, it is possible that HERC2
and E6AP contribute to cellular protein translation by
cooperative interactions with eIF3, eIF4, prefoldin and
mTORC1, and this activity may be enhanced in HPV-positive
cells. Additionally, the HPV genome encodes several proteins
that impact the maintenance of genomic integrity, and recent
studies have shown a strong link between HPV genome
replication and cellular DNA damage.73−75 Given the
involvement of HERC2 in the maintenance of genomic
integrity and repair, high risk HPV E6 proteins may possibly
exert some eﬀect on viral genome replication by establishing
and/or sustaining a cellular DNA repair response through
HERC2.
Iron homeostasis is critical to cellular function and is
dependent upon the iron carrier ferritin. Both ferritin subunits
(FTH1 and FTL) were identiﬁed as HCIPs, linked in both
major HERC2-interaction networks involving intracellular
transport and energy, and bind endogenous HERC2; however,
Figure 5. Colocalization of HERC2 and EIF3E. 293 T-REx cells stably expressing inducible N-HA EIF3E were probed for HA to visualize EIF3E
(green), followed by probing for HERC2 (red). Overlay of HA and HERC2 shows colocalization of EIF3E and HERC2 primarily in the cytoplasm.
Similar colocalization and staining patterns were seen regardless of the order of staining for HA and HERC2, or the ﬂuorophore for each secondary
antibody. Scale bar in the EIF3E panels, 20 μM.
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whether the ferritin−HERC2 interaction is direct remains to be
established. A recent report has suggested a role for HERC2 in
iron metabolism through stability control of FBXL5,15 and
another study provided evidence for NCOA4 as an autophagic
cargo receptor for ferritin, regulating ferritin stability and
turnover upon depletion of intracellular iron.59 In the latter
study, HERC2 was identiﬁed as an interactor of NCOA4 by
mass spectrometry, and here we have corroborated that ﬁnding
by the reciprocal MS analysis. Further studies are necessary to
deﬁne the role of HERC2 in NCOA4 and ferritin biology as
well as intracellular iron homeostasis.
Our analysis also identiﬁed 10 proteasome subunits as
HERC2 HCIPs (33 total proteasomal subunits were identiﬁed
by MS). Given that HERC2 is an ubiquitin ligase and regulator
of protein stability, identiﬁcation of HERC2 association with
the proteasome was not unexpected. The binding of HERC2 to
the proteasome may be direct, to facilitate degradation of
ubiquitylated substrates, or indirect, occurring through E6AP,
as E6AP forms a stable interaction with HERC2 and is known
to bind the proteasome.22,76−80
No reported HERC2 interactors involved in DNA damage
and repair (i.e., RNF8, BRCA1, XPA)7,9,11 were identiﬁed as
HCIPs in our study. This may be a consequence of the cells
used in the analysis, which were not treated to induce DNA
damage, or diﬀerences in the extraction procedure that we used,
or the possibility that adenovirus E1A and/or SV40 large T
antigen, which are expressed in the 293T cells, might perturb
interactions with HERC2. Additional proteomic analyses of
HERC2 under DNA damage conditions may be helpful to
determine whether HERC2−protein interactions are altered
during DNA damage repair.
In summary, we have utilized a novel proteomic approach to
identify potential cellular interacting partners of the giant
ubiquitin ligase HERC2. Our analysis generated well over 200
HCIPs that have not been previously reported to interact with
HERC2. An in-depth bioinformatic analysis placed HERC2 in
new pathways governing critical cellular processes including
protein translation, vesicular traﬃcking, and energy metabolism.
These pathways contribute to the functional versatility of
HERC2 and will undoubtedly lead to new insights in the
dynamics of these processes. This analysis provides a platform
to study HERC2 in important disease contexts including HPV
infection and cancer, as well as Angelman Syndrome and
autism-spectrum disorders. The identiﬁcation of new pathways
involved in those conditions will improve our comprehension
of their etiology and could result in new therapeutic targets for
their treatment.
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